Lessee, Operating Lease, Liability, to be Paid, Year One of Immunovant, Inc. from 30 Jun 2020 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Immunovant, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 30 Jun 2020 to 31 Mar 2024.
  • Immunovant, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Mar 2024 was $141,000, a 88% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $141,000 -$1,057,000 -88% 31 Mar 2024 10-K 29 May 2024 2024 FY
Q1 2023 $1,198,000 -$18,000 -1.5% 31 Mar 2023 10-K 22 May 2023 2023 FY
Q1 2022 $1,216,000 -$74,000 -5.7% 31 Mar 2022 10-K 08 Jun 2022 2022 FY
Q1 2021 $1,290,000 31 Mar 2021 10-K 01 Jun 2021 2020 FY
Q4 2020 $1,198,000 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $1,198,000 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 $1,198,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.